Einat Brill Almon, VP, Product Development at Protalix BioTherapeutics, Inc. (PLX), sold 44,707 shares at $4.00 ($178K) on 2009-05-18, disclosed to the SEC on 2009-05-19.
Open-market sale of $178k PLX by VP, Product Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.79 | 4,707 | $18K | 10.0% |
| 2 | $4.00 | 40,000 | $160K | 90.0% |
| Total | $3.98 avg | 44,707 | $178K | 100% |
| Filing → |
| PLX | SELL | 2010-09-08 | $404K | — | Filing → |
| PLX | SELL | 2009-10-19 | $847K | — | Filing → |
| PLX | SELL | 2009-07-08 | $280K | — | Filing → |